Literature DB >> 15974951

Functions of antimicrobial peptides in host defense and immunity.

Christoph Beisswenger1, Robert Bals.   

Abstract

Antimicrobial peptides (AMPs) are effector molecules of the innate immune system. AMPs have a broad antimicrobial spectrum and lyse microbial cells by interaction with biomembranes. Besides their direct antimicrobial function, they have multiple roles as mediators of inflammation with impact on epithelial and inflammatory cells influencing diverse processes such as cytokine release, cell proliferation, angiogenesis, wound healing, chemotaxis, immune induction, and protease-antiprotease balance. Furthermore, AMPs qualify as prototypes of innovative drugs that may be used as antibiotics, anti-lipopolysaccharide drugs, or modifiers of inflammation. This review summarizes the current knowledge about the basic and applied biology of antimicrobial peptides and discusses features of AMPs in host defense and inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15974951     DOI: 10.2174/1389203054065428

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  32 in total

1.  Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge.

Authors:  H Steffen; S Rieg; I Wiedemann; H Kalbacher; M Deeg; H-G Sahl; A Peschel; F Götz; C Garbe; B Schittek
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 2.  Host defense peptides in wound healing.

Authors:  Lars Steinstraesser; Till Koehler; Frank Jacobsen; Adrien Daigeler; Ole Goertz; Stefan Langer; Marco Kesting; Hans Steinau; Elof Eriksson; Tobias Hirsch
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

Review 3.  Reg3 Proteins as Gut Hormones?

Authors:  Jae Hoon Shin; Randy J Seeley
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

4.  Roles of human beta-defensins in innate immune defense at the ocular surface: arming and alarming corneal and conjunctival epithelial cells.

Authors:  Fabian Garreis; Thomas Schlorf; Dieter Worlitzsch; Philipp Steven; Lars Bräuer; Kristin Jäger; Friedrich P Paulsen
Journal:  Histochem Cell Biol       Date:  2010-06-05       Impact factor: 4.304

5.  Induction of β-defensins by l-isoleucine as novel immunotherapy in experimental murine tuberculosis.

Authors:  C E Rivas-Santiago; B Rivas-Santiago; D A León; J Castañeda-Delgado; R Hernández Pando
Journal:  Clin Exp Immunol       Date:  2011-01-14       Impact factor: 4.330

6.  Effects of human β-defensin 3 fused with carbohydrate-binding domain on the function of type III secretion system in Pseudomonas aeruginosa PA14.

Authors:  Yunqiang Wu; Yanan Liu; Ke Dong; Qingtian Li
Journal:  Braz J Microbiol       Date:  2020-01-13       Impact factor: 2.476

7.  Ocular surface expression and in vitro activity of antimicrobial peptides.

Authors:  Ling C Huang; Daniele Jean; Rita J Proske; Rose Y Reins; Alison M McDermott
Journal:  Curr Eye Res       Date:  2007 Jul-Aug       Impact factor: 2.424

8.  Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans.

Authors:  Linda Johansson; Pontus Thulin; Parham Sendi; Erika Hertzén; Adam Linder; Per Akesson; Donald E Low; Birgitta Agerberth; Anna Norrby-Teglund
Journal:  Infect Immun       Date:  2008-05-19       Impact factor: 3.441

9.  Development of Antimicrobial Peptide Prediction Tool for Aquaculture Industries.

Authors:  Aditi Gautam; Asuda Sharma; Sarika Jaiswal; Samar Fatma; Vasu Arora; M A Iquebal; S Nandi; J K Sundaray; P Jayasankar; Anil Rai; Dinesh Kumar
Journal:  Probiotics Antimicrob Proteins       Date:  2016-09       Impact factor: 4.609

10.  Antimicrobial activity of human prion protein is mediated by its N-terminal region.

Authors:  Mukesh Pasupuleti; Markus Roupe; Victoria Rydengård; Krystyna Surewicz; Witold K Surewicz; Anna Chalupka; Martin Malmsten; Ole E Sörensen; Artur Schmidtchen
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.